Regulatory Rapporteur June 2020
FOCUS: Biotechnology - Why and how regulators should keep pace with innovative biopharmaceutical advances PLUS: • Letter: A ‘SMArt’ new initiative for veterinary legislation • Medical devices: Germany’s new device law, the EU MDR and COVID-19 • E-cigarettes: A look at the regulatory landscape in the US
Regulatory Rapporteur June 2020MEMBERS
Clinical trials with GMOs in the EU – from regulatory to sitesMEMBERS
Review of the US regulatory landscape on electronic nicotine delivery systemsMEMBERS
Exosome-based therapeutics – global regulatory perspectivesMEMBERS
The use of EPARs in regulatory strategy for biologics and advanced therapiesMEMBERS
Quality for biotechnology companies: a safe long-term investmentMEMBERS
Insights on the newly implemented US Pregnancy and Lactation Labeling RuleMEMBERS
Medical device laws in Germany, the impact of COVID-19 and Brexit PUBLIC
Letters: New charity to improve the regulation of veterinary medicines worldwide PUBLIC
Biotechnology – the future becomes the present PUBLIC